{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:16:03Z","timestamp":1783059363665,"version":"3.54.6"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000882","name":"Brain Research Foundation","doi-asserted-by":"publisher","award":["BRFORRG-2018-1"],"award-info":[{"award-number":["BRFORRG-2018-1"]}],"id":[{"id":"10.13039\/100000882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.dadr.2026.100441","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:13:40Z","timestamp":1777648420000},"page":"100441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Attenuation of cue-induced heroin-seeking by the atypical antidepressant mirtazapine"],"prefix":"10.1016","volume":"19","author":[{"given":"Amanda L.","family":"Persons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Celeste","family":"Napier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2026.100441_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.dadr.2026.100441_bib2","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1177\/0269881118764991","article-title":"Mirtazapine attenuates nicotine-seeking behavior in rats","volume":"32","author":"Barbosa-M\u00e9ndez","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.dadr.2026.100441_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejphar.2017.12.033","article-title":"Mirtazapine impairs acquisition and reinstatement of cocaine-induced place preference in rats","volume":"820","author":"Barbosa-M\u00e9ndez","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.dadr.2026.100441_bib4","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1124\/mol.107.041574","article-title":"Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction","volume":"73","author":"Chanrion","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.dadr.2026.100441_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/pr.59.07103","article-title":"5-HT receptor regulation of neurotransmitter release","volume":"59","author":"Fink","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.dadr.2026.100441_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biopsych.2010.09.032","article-title":"Mirtazapine alters cue-associated methamphetamine seeking in rats","volume":"69","author":"Graves","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.dadr.2026.100441_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pharmthera.2012.08.013","article-title":"Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedside","volume":"136","author":"Graves","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.dadr.2026.100441_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2012.07.007","article-title":"The atypical antidepressant mirtazapine attenuates expression of morphine-induced place preference and motor sensitization","volume":"1472","author":"Graves","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.dadr.2026.100441_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.drugalcdep.2008.08.005","article-title":"Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference","volume":"99","author":"Herrold","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2026.100441_bib10","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1111\/ejn.12628","article-title":"Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking","volume":"40","author":"Kousik","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.dadr.2026.100441_bib11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1124\/mol.110.066035","article-title":"Constitutive activity of serotonin2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants","volume":"78","author":"Labasque","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.dadr.2026.100441_bib12","article-title":"Mirtazapine: a one-stop strategy for treatment of opioid withdrawal symptoms","volume":"15","author":"Lalani","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.dadr.2026.100441_bib13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/add.16093","article-title":"Clinical management of psychostimulant withdrawal: review of the evidence","volume":"118","author":"Li","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2026.100441_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pscychresns.2017.10.012","article-title":"Altered anterior cingulate cortex to hippocampus effective connectivity in response to drug cues in men with cocaine use disorder","volume":"271","author":"Ma","year":"2018","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.dadr.2026.100441_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscychresns.2019.08.005","article-title":"Cingulo-hippocampal effective connectivity positively correlates with drug-cue attentional bias in opioid use disorder","volume":"294","author":"Ma","year":"2019","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.dadr.2026.100441_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41398-022-01934-w","article-title":"A serotonergic biobehavioral signature differentiates cocaine use disorder participants administered mirtazapine","volume":"12","author":"Ma","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.dadr.2026.100441_bib17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s13063-024-08238-y","article-title":"A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial","volume":"25","author":"McKetin","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.dadr.2026.100441_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2014.04.007","article-title":"The role of serotonin in drug use and addiction","volume":"277","author":"M\u00fcller","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.dadr.2026.100441_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/pharmrev.121.000367","article-title":"Sex differences in opioid and psychostimulant craving and relapse: a critical review","volume":"74","author":"Nicolas","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.dadr.2026.100441_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainres.2006.09.050","article-title":"Effects of the 5-HT2A antagonist mirtazapine in rat models of thermoregulation","volume":"1123","author":"Pawlyk","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.dadr.2026.100441_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pnpbp.2017.03.027","article-title":"Mirtazapine and ketanserin alter preference for gambling-like schedules of reinforcement in rats","volume":"77","author":"Persons","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.dadr.2026.100441_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108746","article-title":"Gut and brain profiles that resemble pre-motor and early-stage Parkinson's disease in methamphetamine self-administering rats","volume":"225","author":"Persons","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2026.100441_bib24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tins.2021.02.001","article-title":"Modulating the neuromodulators: dopamine, serotonin, and the endocannabinoid system","volume":"44","author":"Peters","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.dadr.2026.100441_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2008-2231-22-13","article-title":"Pharmacokinetics of mirtazapine and its main metabolites after single intravenous and oral administrations in rats at two dose rates","volume":"22","author":"Rouini","year":"2014","journal-title":"Daru"},{"key":"10.1016\/j.dadr.2026.100441_bib26","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/npp.2016.287","article-title":"Incubation of methamphetamine but not heroin craving after voluntary abstinence in male and female rats","volume":"42","author":"Venniro","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.dadr.2026.100441_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnbeh.2011.00092","article-title":"Context-dependent effects of a single administration of mirtazapine on the expression of methamphetamine-induced conditioned place preference","volume":"5","author":"Voigt","year":"2012","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.dadr.2026.100441_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbr.2011.07.009","article-title":"Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats","volume":"225","author":"Voigt","year":"2011","journal-title":"Behav. Brain Res."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277272462600034X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277272462600034X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:19:33Z","timestamp":1783055973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277272462600034X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"alternative-id":["S277272462600034X"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2026.100441","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attenuation of cue-induced heroin-seeking by the atypical antidepressant mirtazapine","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2026.100441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100441"}}